Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by skys1on Jun 26, 2022 3:43pm
325 Views
Post# 34783288

RE:RE:Money raise coming soon?

RE:RE:Money raise coming soon?"Money raise coming soon", is pure nonsense! How many times does management have to tell you they have enough funds toget them through the Ph 2 process before you will believe them? Plus recently they have gotten additional revenue from the exercise of warrants and now they are hiring additional high level people with appropriate salaries. That wouldn't imply a cash need. In the next several months when they get BTD & AA it will be a new ballgame with possible revenue from their  ACT treatments and I suspect a completely different corporate structure. IMO, there is no way big pharma will allow this upstart with an ACT that is substantially better than the current standard of treatment to operate and grow it's treatment portfolio and market presence. It could be Li Ka Shing or whoever, but I believe this time next year TLT will be part of the big pharma world and a valuation many multiples of it's current value.  
<< Previous
Bullboard Posts
Next >>